Pengo, V <br/><br/>
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Oct 2012 
 - 1979-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/j.1538-7836.2012.04866.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--administration & dosage<br/>Atrial Fibrillation--blood<br/>Benzimidazoles--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Dabigatran<br/>Evidence-Based Medicine<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Morpholines--administration & dosage<br/>Patient Safety<br/>Preventive Health Services<br/>Pyrazoles--administration & dosage<br/>Pyridones--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Rivaroxaban<br/>Stroke--blood<br/>Thiophenes--administration & dosage<br/>Treatment Outcome<br/>Warfarin--administration & dosage<br/>beta-Alanine--administration & dosage